Erratum: Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma

Am J Cancer Res. 2023 Nov 15;13(11):5746-5747. eCollection 2023.

¹ Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School Nanjing 210008, Jiangsu, China.
² Department of Gastroenterology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University Nanjing 210008, Jiangsu, China.
³ Division of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University Wenzhou 325000, Zhejiang, China.
⁴ Department of Surgery, Technical University of Munich Munich 80333, Germany.
⁵ Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic and Mayo Clinic Cancer Center Rochester 55905, MN, US.

Abstract

[This corrects the article on p. 546 in vol. 9, PMID: 30949409.].